Clinical Trial Update: A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis [Phase 2]

View source ↗

Summary

Verona Pharma is conducting a Phase II study of ensifentrine for non-cystic fibrosis bronchiectasis; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cystic Fibrosis Bronchiectasis

Drugs mentioned

• Ensifentrine (ensifentrine)

Snippet

Sponsor: Verona Pharma plc | Conditions: Non-cystic Fibrosis Bronchiectasis | Phase 2 | Status: RECRUITING